Please set your featured image
BioMarin Pharmaceutical Inc. announces name change for Prosensa Therapeutics B.V.
BioMarin Pharmaceutical Inc. announces that Prosensa Therapeutics B.V., a BioMarin company, changed its name to BioMarin Nederland B.V. This name change reflects the further integration of Prosensa into BioMarin.
BioMarin acquired Prosensa on Jan. 15, 2015. BioMarin maintains operations at the former Prosensa headquarters, based in Leiden, The Netherlands and has integrated personnel from that office into the company.
“We are pleased that the integration of Prosensa employees into the BioMarin family is going smoothly. We share a common purpose of delivering therapies that will make a meaningful difference to patients with rare genetic diseases,” said Scott Clarke, Site Leader, BioMarin Nederland. “Together, we are working to bring treatments to boys with Duchenne muscular dystrophy.”
Read the full article at BioSpace
Prosensa’s Oxford office has been based at Begbroke Science Park since 2010.